Delivery Order SPE2DB22D2005-SPE2DB24FJJN7
Award Date 3/5/24
Potential Completion Date 3/26/24
Potential Value $4.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order contract worth $3,373.68 by the Defense Logistics Agency (DLA) to provide HYPERRAB 300 UNIT/ML VIAL 3ML pharmaceuticals. The contract has a completion date of March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designations. The company also holds an Indefinite Delivery Contract with DLA worth up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,756.72 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563892824 - HYPERRAB 300 UNIT/ML VIAL 5ML. The contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA). The firm-fixed-price, $9,391.75 contract has a completion date of July 1, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HYPERRAB 300 UNIT/ML VIALML pharmaceutical products. The $3,721.90 Firm Fixed Price contract has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of...
- The U.S. government awarded a delivery order contract worth $11,270.10 to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to federal agencies. The contract, which has a firm fixed price, is to provide the Defense Logistics Agency (DLA) Troop Support Medical with HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the supply of a pharmaceutical product, HYPERRAB 300 UNIT/ML VIAL, to the Defense Logistics Agency (DLA). The $4,466.28 firm fixed-price delivery order has a performance period through June 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This is a $7,513.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,259 units of the pharmaceutical product HYPERRAB 300 UNIT/ML VIAL 5ML. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., will provide these critical medical supplies to support government healthcare programs. The contract has an ultimate completion date of August 16,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of a specialty pharmaceutical product, HYPERRAB 300 UNIT/ML VIALML, with a potential value of $4,466.28 and a completion date of February 22, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The delivery order is valued at $3,756.72 and has a firm fixed-price pricing structure. The ultimate completion date for this contract is August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML medical products. The $11,031.48 firm fixed price contract has a completion date of March 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical...